These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22082484)

  • 1. Involvement of IL-1R/TLR signalling in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ruggiero V
    Curr Mol Med; 2012 Mar; 12(3):218-36. PubMed ID: 22082484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
    Gooshe M; Abdolghaffari AH; Gambuzza ME; Rezaei N
    Rev Neurosci; 2014; 25(5):713-39. PubMed ID: 24914714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pellino proteins: novel players in TLR and IL-1R signalling.
    Schauvliege R; Janssens S; Beyaert R
    J Cell Mol Med; 2007; 11(3):453-61. PubMed ID: 17635639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
    Fitzpatrick JK; Downer EJ
    Neuropharmacology; 2017 Feb; 113(Pt B):618-626. PubMed ID: 27079840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin and metallothioneins as molecular base for sex-dependent differences in clinical course of experimental autoimmune encephalomyelitis in chronic iron overload.
    Ćurko-Cofek B; Grubić Kezele T; Barac-Latas V
    Med Hypotheses; 2017 Sep; 107():51-54. PubMed ID: 28915963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in multiple sclerosis.
    Racke MK; Drew PD
    Curr Top Microbiol Immunol; 2009; 336():155-68. PubMed ID: 19688333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
    Paré A; Mailhot B; Lévesque SA; Lacroix S
    Brain Behav Immun; 2017 May; 62():1-8. PubMed ID: 27432634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
    Gambuzza M; Licata N; Palella E; Celi D; Foti Cuzzola V; Italiano D; Marino S; Bramanti P
    J Neuroimmunol; 2011 Oct; 239(1-2):1-12. PubMed ID: 21889214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γδ T lymphocytes in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    Zarobkiewicz MK; Kowalska W; Roliński J; Bojarska-Junak AA
    J Neuroimmunol; 2019 May; 330():67-73. PubMed ID: 30831520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TLR/IL-1R signalling in human diseases.
    Loiarro M; Ruggiero V; Sette C
    Mediators Inflamm; 2010; 2010():674363. PubMed ID: 20396389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemokines and their receptors in the pathogenesis of multiple sclerosis.
    Sindern E
    Front Biosci; 2004 Jan; 9():457-63. PubMed ID: 14766382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.
    Prado C; Gaiazzi M; González H; Ugalde V; Figueroa A; Osorio-Barrios FJ; López E; Lladser A; Rasini E; Marino F; Zaffaroni M; Cosentino M; Pacheco R
    Front Immunol; 2018; 9():571. PubMed ID: 29619030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Lin CC; Edelson BT
    J Immunol; 2017 Jun; 198(12):4553-4560. PubMed ID: 28583987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis.
    Zheng C; Chen J; Chu F; Zhu J; Jin T
    Front Mol Neurosci; 2019; 12():314. PubMed ID: 31998072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases.
    Schauvliege R; Janssens S; Beyaert R
    FEBS Lett; 2006 Aug; 580(19):4697-702. PubMed ID: 16884718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis.
    Wu H; Li XM; Wang JR; Gan WJ; Jiang FQ; Liu Y; Zhang XD; He XS; Zhao YY; Lu XX; Guo YB; Zhang XK; Li JM
    J Pathol; 2016 Feb; 238(3):457-69. PubMed ID: 26564988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
    Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
    J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.